EN ISO 13485:2016 – Amendment 11 has been published!
The European standardisation bodies CEN and CENELEC published EN ISO 13485:2016+A11:2021 featuring new annexes ZA and ZB that link the requirements of the MDR (Regulation EU 2017/745) and the IVDR (Regulation EU 2017/746), respectively, to specific clauses of the standard.
Liliana Teles

Liliana Teles

Regulatory Affairs Manager

On the 9th of September, the European standardisation bodies CEN and CENELEC published the 2021 amendment, EN ISO 13485:2016+A11:2021 – ‘Medical devices – Quality management systems – Requirements for regulatory purposes’, featuring new annexes ZA and ZB that link the requirements of the Medical Device Regulation (MDR, EU 2017/745) and the In Vitro Diagnostics Regulation (IVDR, EU 2017/746), respectively, to specific clauses of the standard.

EN ISO 13485:2016+A11:2021 provides regulatory requirements for the manufacturer’s Quality Management System (QMS) that ensures consistent design, development, production, installation, and delivery of medical devices. Although ISO 13485:2016 is not mandatory for EU MDR/IVDR compliance, it is a commonly acknowledged standard to demonstrate the compliance to the MDR/IVDR requirement of having a QMS implemented.

What is new?

The new Annexes link clauses of the standard with requirements in the MDR and IVDR on:

– The general obligations of the manufacturer in MDR/IVDR Article 10 (Tables ZA1 for MDR and ZB1 for IVDR);

– The quality management system (QMS) requirements in MDR/IVDR Annex IX on conformity assessment based on a QMS and on assessment of technical documentation (Table ZA2 for MDR and ZB2 for IVDR); and

– The QMS requirements in MDR/IVDR Annex XI on conformity assessment based on product conformity verification (Table ZA3 for MDR and ZB3 for IVDR).

Annexes ZA and ZB publication now clarifies where compliance with the standard is not sufficient, or only partly sufficient, to meet EU regulatory requirements.

It is expected that the European Commission will add EN ISO 13485:2016+A11:2021 to the slowly growing list of standards harmonized under the MDR and the IVDR before the end of 2021, once reference to this standard is published in the Official Journal of the European Union, which would then allow medical device manufacturers to claim a presumption of conformity with identified clauses of the MDR/IVDR.

The current list of standards harmonized under the MDR/IVDR can be accessed here.

If you wish to know more information about amendment EN ISO 13485:2016+A11:2021 – ‘Medical devices – Quality management systems – Requirements for regulatory purposes’ feel free to contact us at info@criticalcatalyst.com.

further
reading

medical devices

EUDAMED – harmonized practices and alternative solutions for IVDR until the database is fully functional

EUDAMED is one of the key aspects of the new rules on in vitro diagnostic medical devices – Regulation (EU) 2017/746. However, it is only expected to achieve full functionality by the second quarter of 2024. Until then, how is the information submitted and/or exchanged between manufacturers, notified bodies and competent authorities?

Read More »
medical devices

EUDAMED – update on timelines

EUDAMED is one of the key aspects of the new rules on medical devices (Regulation (EU) 2017/745) and in vitro diagnostic medical devices (Regulation (EU) 2017/746), and it is expected to achieve full functionality by the second quarter of 2024.

Read More »
cosmetic products

UK OPSS call for data on six cosmetic ingredients

On 14 July 2022, the Office for Product Safety and Standards (OPSS – the UK regulator for cosmetic products) issued a call for data on the safety of the following six cosmetic ingredients to investigate any suspected endocrine disrupting properties. 

Read More »
cosmetic products

European Commission Recommendation on the Definition of Nanomaterial

Nanomaterials are increasingly used in cosmetics and personal care products. They are similar to other chemicals/substances, but with specific risks associated to their use. The European Commission has published a new Recommendation to clarify the definition of ‘nanomaterial’. This definition may serve different policy, legislative and research purposes when addressing materials or issues concerning products of nanotechnologies.

Read More »
cosmetic products

Expected Restriction on the Use of Methyl Salicylate

The European Commission has notified the World Trade Organization (WTO) of a draft amendment to the Regulation (EC) No. 1223/2009 on cosmetic products. Annex III to Regulation will be amended, and the use of Methyl Salicylate in cosmetic products will be restricted.

Read More »
cosmetic products

Environmental Labelling of Cosmetic Products in Italy and France

Although the European Cosmetics Regulation is applicable to every cosmetic product made available in the European Union market, some national legislations may also apply. Environmental regulations in Italy and France specify mandatory labelling requirements applicable to products marketed in these countries.

Read More »